A Phase III Clinical Trial of Quadrivalent Influenza Vaccine in Healthy Subjects Aged 6 to 35 Months

Condition:   Seasonal Influenza Interventions:   Biological: Quadrivalent influenza vaccine(0.25ml);   Biological: Quadrivalent influenza vaccine(0.5ml);   Biological: Trivalent influenza vaccine(BV);   Biological: Trivalent influenza vaccine(BY) Sponsor:   Sinovac Biotech Co., Ltd Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials